In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications

A Refaat, ML Yap, G Pietersz, APG Walsh… - Journal of …, 2022 - Springer
Advances in diagnostic imaging have provided unprecedented opportunities to detect
diseases at early stages and with high reliability. Diagnostic imaging is also crucial to …

Developments in the treatment of Fabry disease

SJ van der Veen, CEM Hollak… - Journal of inherited …, 2020 - Wiley Online Library
Enzyme replacement therapy (ERT) with recombinant α‐galactosidase A (r‐αGAL A) for the
treatment of Fabry disease has been available for over 15 years. Long‐term treatment may …

Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review …

SA Woolen, PR Shankar, JJ Gagnier… - JAMA internal …, 2020 - jamanetwork.com
Importance Risk of nephrogenic systemic fibrosis (NSF) to individual patients with stage 4 or
5 chronic kidney disease (CKD; defined as estimated glomerular filtration rate of< 30 …

Consensus-based technical recommendations for clinical translation of renal ASL MRI

F Nery, CE Buchanan, AA Harteveld, A Odudu… - … Resonance Materials in …, 2020 - Springer
Objectives This study aimed at developing technical recommendations for the acquisition,
processing and analysis of renal ASL data in the human kidney at 1.5 T and 3 T field …

Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview

A Falk Delgado, D Van Westen, M Nilsson… - Insights into …, 2019 - Springer
Gadolinium-based contrast agents (GBCAs) increase lesion detection and improve disease
characterization for many cerebral pathologies investigated with MRI. These agents …

Direct mapping of kidney function by DCE-MRI urography using a tetrazinanone organic radical contrast agent

ND Calvert, A Kirby, M Suchý, P Pallister… - Nature …, 2023 - nature.com
Chronic kidney disease (CKD) and acute kidney injury (AKI) are ongoing global health
burdens. Glomerular filtration rate (GFR) is the gold standard measure of kidney function …

Nephrogenic systemic fibrosis in patients with chronic kidney disease after the use of gadolinium-based contrast agents: a review for the cardiovascular imager

S Gallo-Bernal, N Patino-Jaramillo, CA Calixto… - Diagnostics, 2022 - mdpi.com
Gadolinium-enhanced cardiac magnetic resonance has revolutionized cardiac imaging in
the last two decades and has emerged as an essential and powerful tool for the …

Canadian Association of Radiologists recommendations for the safe use of MRI during pregnancy

P Jabehdar Maralani, A Kapadia… - Canadian …, 2022 - journals.sagepub.com
The use of magnetic resonance imaging (MRI) during pregnancy is associated with
concerns among patients and health professionals with regards to fetal safety. In this work …

Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: Recommendations for use

G Petralia, F Zugni, PE Summers, A Colombo… - La radiologia …, 2021 - Springer
Whole-body magnetic resonance imaging (WB-MRI) is currently recommended for cancer
screening in adult and paediatric subjects with cancer predisposition syndromes …

Mn (II) complex of lipophilic group-modified ethylenediaminetetraacetic acid (EDTA) as a new hepatobiliary MRI contrast agent

K Chen, P Li, C Zhu, Z Xia, Q Xia, L Zhong… - Journal of Medicinal …, 2021 - ACS Publications
Liver-specific contrast agents (CAs) can improve the Magnetic resonance imaging (MRI)
detection of focal and diffuse liver lesions by increasing the lesion-to-liver contrast. A novel …